Comment on Drozdowska-Szymczak et al. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease-A Case-Control Study. J. Clin. Med. 2024, 13, 3190

Jonas Teng^{1

2}, Björn Fischler^{1

3}, Kajsa Bohlin^{1

4}, Marie Reilly⁵, Eleonor Tiblad⁶

Affiliations

¹ Division of Pediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, 141 52 Huddinge, Sweden.
² Department of Pediatrics, Södertälje Hospital, 152 86 Södertälje, Sweden.
³ Department of Pediatrics, Karolinska University Hospital, 141 86 Stockholm, Sweden.
⁴ Department of Neonatology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, 141 86 Stockholm, Sweden.
⁵ Department of Medical Epidemiology & Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden.
⁶ Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, 171 77 Stockholm, Sweden.

Jonas Teng et al. J Clin Med. 2024.

. 2024 Nov 22;13(23):7047.

doi: 10.3390/jcm13237047.

Jonas Teng^{1

2}, Björn Fischler^{1

3}, Kajsa Bohlin^{1

4}, Marie Reilly⁵, Eleonor Tiblad⁶

¹ Division of Pediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, 141 52 Huddinge, Sweden.
² Department of Pediatrics, Södertälje Hospital, 152 86 Södertälje, Sweden.
³ Department of Pediatrics, Karolinska University Hospital, 141 86 Stockholm, Sweden.
⁴ Department of Neonatology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, 141 86 Stockholm, Sweden.
⁵ Department of Medical Epidemiology & Biostatistics, Karolinska Institutet, 171 77 Stockholm, Sweden.
⁶ Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, 171 77 Stockholm, Sweden.

Abstract

We read with interest the recently published article in the Journal of Clinical Medicine, by Drozdowska-Szymczak et al [...].

The authors declare no conflicts of interest.

1. Drozdowska-Szymczak A., Mazanowska N., Pomianek T., Ludwin A., Krajewski P. Incidence and Risk Factors of Cholestasis in Newborns with Hemolytic Disease—A Case-Control Study. J. Clin. Med. 2024;13:3190. doi: 10.3390/jcm13113190. - DOI - PMC - PubMed
1. Fawaz R., Baumann U., Ekong U., Fischler B., Hadzic N., Mack C.L., McLin V.A., Molleston J.P., Neimark E., Ng V.L., et al. Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastroenterol. Nutr. 2017;64:154–168. doi: 10.1097/MPG.0000000000001334. - DOI - PubMed
1. Smits-Wintjens V.E., Rath M.E., Lindenburg I.T., Oepkes D., van Zwet E.W., Walther F.J., Lopriore E. Cholestasis in neonates with red cell alloimmune hemolytic disease: Incidence, risk factors and outcome. Neonatology. 2012;101:306–310. doi: 10.1159/000335333. - DOI - PubMed
1. Teng J., Wickman L., Reilly M., Nemeth A., Fischler B., Bohlin K., Tiblad E. Population-based incidence and risk factors for cholestasis in hemolytic disease of the fetus and newborn. J. Perinatol. 2022;42:702–707. doi: 10.1038/s41372-022-01345-1. - DOI - PMC - PubMed